Cited by 193Electrolyte and hormonal disordersHeart Failure Treatment and ManagementIon Transport and Channel Regulation

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Antidiuretic hormone in congestive heart failure.

Riegger, Günther A.J., Liebau, Gerhart, Kochsiek, Kurt·1982·The American Journal of Medicine

DOI 10.1016/0002-9343(82)90576-9

Open this paper in CoChat — free account

Abstract

In advanced heart failure, severe edema develops associated with hyponatremia. In 20 patients with severe congestive heart failure, we studied plasma antidiuretic hormone (ADH) concentrations related to hemodynamics and plasma osmolality. Prazosin was used to test the acute response to changes in atrial receptors and hemofiltration to test the response to changes in volume receptors. One group of the patients had inappropriately high ADH values (14.5 +/- 8.8 pg/ml) in relation to their plasma osmolality, which was well below normal values (276 +/- 23 mosmol/kg water) with no apparent osmoregulatory control. The other group showed a normal relationship of ADH and plasma osmolality (3.9 +/- 1.0 pg/ml; 289 +/- 8 mosmol/kg water), Only in the normal regulating group did lowering of left atrium pressure by prazosin result in a rise in ADH related to the decrease in pressure. Inappropriately high ADH secretion could be reversed by hemofiltration. This suggests that the syndrome of "dilutional hypo-osmolality" in severe congestive heart failure may be caused by an inappropriately high ADH secretion in which the osmoreceptor system is dominated by nonosmolar stimuli; however, it cannot be ruled out that associated hemodynamic effects in the kidney or other intrarenal or hormonal factors contribute to this mechanism.

Integrity signals

Registry

Crossref · 10.1016/0002-9343(82)90576-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Croonian Lecture - The antidiuretic hormone and the factors which determine its release
Verney, E. B. (1947) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1947.0037 · Cited by 1,103
The osmoregulation of vasopressin
Robertson, G. L., Shelton, R. L., & Athar, S. (1976) · Kidney International · doi:10.1038/ki.1976.76 · Cited by 527
EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF “FORWARD FAILURE” AS THE PRIMARY CAUSE OF EDEMA 1
Merrill, A. J. (1946) · Journal of Clinical Investigation · doi:10.1172/jci101720 · Cited by 357
The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
Watkins, L., Burton, J. A., Haber, E., Cant, J. R., Smith, F. W., & Barger, A. C. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108431 · Cited by 302
The possible role of cardiac atrial stretch receptors in the induction of changes in urine flow
Henry, J. P., & Pearce, J. W. (1956) · The Journal of Physiology · doi:10.1113/jphysiol.1956.sp005483 · Cited by 224
A study of right and left atrial receptors
Paintal, A. S. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004920 · Cited by 210
Impaired Atrial Receptor Responses in Dogs with Heart Failure Due to Tricuspid Insufficiency and Pulmonary Artery Stenosis
GREENBERG, T. T., Richmond, W., STOCKING, R. A., GUPTA, P. D., MEEHAN, J. P., & Henry, J. P. (1973) · Circulation Research · doi:10.1161/01.res.32.4.424 · Cited by 144
The Kidney in Heart Failure
Cannon, P. (1977) · New England Journal of Medicine · doi:10.1056/nejm197701062960108 · Cited by 133
Nonosmolar Factors Affecting Renal Water Excretion
Schrier, R. W., & Berl, T. (1975) · New England Journal of Medicine · doi:10.1056/nejm197501092920207 · Cited by 131
A RADIOIMMUNOASSAY FOR PLASMA ARGININE-VASOPRESSIN IN MAN AND DOG: APPLICATION TO PHYSIOLOGICAL AND PATHOLOGICAL STATES
Morton, J. J., Padfield, P. L., & Forsling, M. L. (1975) · Journal of Endocrinology · doi:10.1677/joe.0.0650411 · Cited by 105

Show all 25 references

Research works printed but not linked: 3

Bokyin, 1974, Mechanism of the diuretic effect of atrial tachycardia, Clin Res, 22, 265
Yaron, 1978, Renal sodium handling in, acute right-sided heart failure in dogs, Min Electrolyt Metab, 1, 303
Davis, 1965, The physiology of congestive heart failure, vol. 3

Pathophysiology of Heart Failure
Tanai, E., & Frantz, S. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140055 · Cited by 552
The Neurohumoral Axis in Congestive Heart Failure
FRANCIS, G. S., GOLDSMITH, S. R., LEVINE, T. B., OLIVARI, M. T., & COHN, J. N. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-370 · Cited by 600
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
Lee, W. H., & Packer, M. (1986) · Circulation · doi:10.1161/01.cir.73.2.257 · Cited by 552
Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and Pregnancy
Schrier, R. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191705 · Cited by 497
Prostaglandins in Severe Congestive Heart Failure: Relation to Activation of the Renin–Angiotensin System and Hyponatremia
Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K., & Williams, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100603 · Cited by 428
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.
Anand, I. S., Ferrari, R., Kalra, G. S., Wahi, P. L., Poole-Wilson, P. A., & Harris, P. C. (1989) · Circulation · doi:10.1161/01.cir.80.2.299 · Cited by 375
Acute Hemodynamic Effects of Conivaptan, a Dual V 1A and V 2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure
Udelson, J. E., Smith, W. B., Hendrix, G. H., Painchaud, C. A., Ghazzi, M., Thomas, I., Ghali, J. K., Selaru, P., Chanoine, F., Pressler, M. L., et al. (2001) · Circulation · doi:10.1161/hc4501.099313 · Cited by 362
Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and Pregnancy
Schrier, R. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191606 · Cited by 348
New approach to disturbances in the plasma sodium concentration
Rose, B. D. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90401-8 · Cited by 239
Vasopressin Antagonism in Heart Failure
Goldsmith, S. R., & Gheorghiade, M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.095 · Cited by 228
The Renin-Angiotensin-Aldosterone System, Antidiuretic Hormone and Sympathetic Nerve Activity in an Experimental Model of Congestive Heart Failure in the Dog
Riegger, A. J. G., & Liebau, G. (1982) · Clinical Science · doi:10.1042/cs0620465 · Cited by 210
Self-citation
Prerenal Failure: A Deleterious Shift from Renal Compensation to Decompensation
Epstein, F. H., Badr, K. F., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809083191007 · Cited by 199
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system
Creager, M. A., Faxon, D. P., Cutler, S. S., Kohlmann, O., Ryan, T. J., & Gavras, H. P. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80333-3 · Cited by 194
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemia
Leier, C. V., Cas, L. D., & Metra, M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90633-5 · Cited by 190
Plasma and platelet vasopressin in essential hypertension and congestive heart failure.
Preibisz, J., Sealey, J. E., Laragh, J. H., Cody, R. J., & Weksler, B. B. (1983) · Hypertension · doi:10.1161/01.hyp.5.2_pt_2.i129 · Cited by 184
Diuretic treatment and diuretic resistance in heart failure
Krämer, B. K., Schweda, F., & Riegger, G. A. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00365-9 · Cited by 183
Self-citation
Evaluation and management of hypo-osmolality in hospitalized patients
Janicic, N., & Verbalis, J. G. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00004-5 · Cited by 173
The extended autonomic system, dyshomeostasis, and COVID-19
Goldstein, D. S. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00714-0 · Cited by 151
Renal and circulatory mechanisms in congestive heart failure
Dzau, P. D. V. J. (1987) · Kidney International · doi:10.1038/ki.1987.156 · Cited by 138
The pathophysiology of myocardial infarction-induced heart failure
Gabriel‐Costa, D. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.04.003 · Cited by 133
Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients
Abraham, W. T., Shamshirsaz, A. A., McFann, K., Oren, R. M., & Schrier, R. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.071 · Cited by 130
Correction of Dilutional Hyponatremia in Severe Chronic Heart Failure by Converting-Enzyme Inhibition
Packer, M., Medina, N., & Yushak, M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-782 · Cited by 121
Pathophysiological roles of arginine vasopressin and aquaporin‐2 in impaired water excretion
Ishikawa, S., & Schrier, R. W. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01647.x · Cited by 112
Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure
Packer, M., Medina, N., & Yushak, M. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80364-2 · Cited by 112
Arginine vasopressin and the renal response to water loading in congestive heart failure
Goldsmith, S. R., Francis, G. S., & Cowley, A. W. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90065-2 · Cited by 111
Hemodynamic effects of infused arginine vasopressin in congestive heart failure
Goldsmith, S. R., Francis, G. S., Cowley, A. W., Goldenberg, I. F., & Cohn, J. N. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80417-x · Cited by 108
Sympathetic Activation in Heart Failure and Its Treatment With β-Blockade
Pepper, G. S., & Lee, R. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.225 · Cited by 106
Evidence for a Vasopressin System in the Rat Heart
Hupf, H., Grimm, D. G., Riegger, G. A. J., & Schunkert, H. (1999) · Circulation Research · doi:10.1161/01.res.84.3.365 · Cited by 105
Self-citation
Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V1A receptor
Nakamura, Y., Haneda, T., Osaki, J., 宮田, 節., & Kikuchi, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00775-x · Cited by 102
Hyponatremia in Congestive Heart Failure: Implications for Neurohumoral Activation and Responses to Orthostasis*
Lilly, L. S., Dzau, V. J., Williams, G. H., Rydstedt, L. L., & Hollenberg, N. K. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-924 · Cited by 101
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction
Udelson, J. E., Bilsker, M., Hauptman, P. J., Sequeira, R. F., Thomas, I., O’Brien, T. X., Zimmer, C., Orlandi, C., & Konstam, M. A. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.08.005 · Cited by 99
Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study
Goldsmith, S. R., Elkayam, U., Haught, W. H., Barve, A. J., & He, W. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.003 · Cited by 98
Hyponatraemia: more than just a marker of disease severity?
Schrier, R. W., Sharma, S., & Shchekochikhin, D. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.246 · Cited by 94
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure
Bichet, D. G., Kortas, C., Mettauer, B., Manzini, C., Marc-Aurèle, J., Rouleau, J. L., & Schrier, R. W. (1986) · Kidney International · doi:10.1038/ki.1986.126 · Cited by 92
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin
Kalra, P. R. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00297-8 · Cited by 91
Vasopressin as vasopressor
Goldsmith, S. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90228-2 · Cited by 90
Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal study
Ribner, H. S., Plucinski, D. A., Hsieh, A., Bresnahan, D. R., Molteni, A., Askenazi, J., & Lesch, M. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90778-7 · Cited by 90
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade
Riegger, G. A. J., Liebau, G., Holzschuh, M., Witkowski, D., Steilner, H., & KOCHSIEK, K. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90040-7 · Cited by 90
Self-citation
Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor
Fukuzawa, J., Haneda, T., & Kikuchi, K. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006980517557 · Cited by 89
Review of Current and Investigational Pharmacologic Agents for Acute Heart Failure Syndromes
Shin, D. D., Brandimarte, F., Luca, L. D., Sabbah, H. N., Fonarow, G. C., Filippatos, G. S., Michel Komajda, N., & Gheorghiade, M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.025 · Cited by 88
Hyponatremia in Patients with Heart Failure
Luca, L. D., Klein, L., Udelson, J. E., Orlandi, C., Sardella, G., Fedele, F., & Gheorghiade, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.066 · Cited by 88
Pathophysiology of Sodium and Water Retention in Heart Failure
Cadnapaphornchai, M. A., Gurevich, A. K., Weinberger, H. D., & Schrier, R. W. (2001) · Cardiology · doi:10.1159/000047396 · Cited by 85
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure
NICOD, P. H., Waeber, B., Bussien, J. P., Goy, J. J., Turini, G. A., Nussberger, J., Hofbauer, K. G., & Brunner, H. R. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90743-x · Cited by 83
Role of volume in the regulation of vasopressin secretion during pregnancy in the rat.
Barron, W. M., Stamoutsos, B. A., & Lindheimer, M. D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111316 · Cited by 78
Stress and the “extended” autonomic system
Goldstein, D. S. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102889 · Cited by 77
Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients
GROSS, P. A., Pehrisch, H., Rascher, W., Schömig, A., Hackenthal, E., & Ritz, E. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb02391.x · Cited by 77
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure
Malmsjö, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00062-0 · Cited by 68
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure
Nakamura, T., Funayama, H., Yoshimura, A., Tsuruya, Y., Saito, M., Kawakami, M., & Ishikawa, S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.043 · Cited by 67
Esophageal Disorders in the Elderly
Castell, D. O. (1990) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00495-7 · Cited by 67
The Biology of Vasopressin
Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C. M., Bardies, M., Barrow, B., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010089 · Cited by 65
Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure
Funayama, H., Nakamura, T., Saitô, T., Yoshimura, A., Saito, M., Kawakami, M., & Ishikawa, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00902.x · Cited by 64
Pharmacology of New Agents for Acute Heart Failure Syndromes
Gheorghiade, M., Teerlink, J. R., & Mebazaa, A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.023 · Cited by 61
Role of Antidiuretic Hormone in Impaired Water Excretion of Patients with Congestive Heart Failure*
Pruszczynski, W., Vahanian, A. S., Ardaillou, R., & Acar, J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-4-599 · Cited by 61
Renal and Electrolyte Complications of Congestive Heart Failure and Effects of Therapy With Angiotensin-Converting Enzyme Inhibitors
Oster, J. R. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400160022006 · Cited by 58
Effect of vasopressin antagonist on water excretion in inferior vena cava constriction
Ishikawa, S., Saito, T., Okada, K., Tsutsui, K., & Kuzuya, T. (1986) · Kidney International · doi:10.1038/ki.1986.149 · Cited by 58
The Cardiorenal Syndrome: Making the Connection
Viswanathan, G., & Gilbert, S. (2010) · International Journal of Nephrology · doi:10.4061/2011/283137 · Cited by 57
Vasopressin: A therapeutic target in congestive heart failure?
Goldsmith, S. R. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91339-8 · Cited by 53
Hormonal Abnormalities Affecting Sodium and Water Balance in Acute Respiratory Failure Due to Chronic Obstructive Lung Disease
Farber, M. O., Weinberger, M. H., Robertson, G. L., Fineberg, N. S., & Manfredi, F. (1984) · CHEST Journal · doi:10.1378/chest.85.1.49 · Cited by 51
Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.
Arnolda, L., McGrath, B. P., Cocks, M., & Johnston, C. I. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112626 · Cited by 50
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy
Riegger, G. A. J., & KOCHSIEK, K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90066-4 · Cited by 48
Self-citation
Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
Riegger, G. A. J., Kahles, H. W., Elsner, D., Kromer, E. P., & KOCHSIEK, K. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80007-5 · Cited by 48
Self-citation
Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
Mulinari, R. A., Gavras, I., Wang, Y. X., Franco, R. J. D. S., & Gavras, H. (1990) · Circulation · doi:10.1161/01.cir.81.1.308 · Cited by 47
The Critical Link of Hypervolemia and Hyponatremia in Heart Failure and the Potential Role of Arginine Vasopressin Antagonists
Ghali, J. K., & Tam, S. W. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.12.021 · Cited by 46
Renal Hemodynamic Consequences of Angiotensin-Converting Enzyme Inhibition in Congestive Heart Failure
Suki, W. N. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390030125024 · Cited by 46
Recent Advances in the Understanding of Water Metabolism in Heart Failure
Schrier, R. W., & Martin, P.-Y. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_53 · Cited by 45
Tolvaptan for the treatment of heart failure: a review of the literature
Ambrosy, A. P., Goldsmith, S. R., & Gheorghiade, M. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.567267 · Cited by 43
Overview of Emerging Pharmacologic Agents for Acute Heart Failure Syndromes
Luca, L. D., Mebazaa, A., Filippatos, G. S., Parissis, J., Böhm, M., Voors, A. A., Nieminen, M. S., Zannad, F. M., Rhodes, A., El-Banayosy, A., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.002 · Cited by 43
Congestive Heart Failure: Potential Role of Arginine Vasopressin Antagonists in the Therapy of Heart Failure
Goldsmith, S. R. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.01158.x · Cited by 42
Early Development of Hyponatremia Implicates Short- and Long-Term Outcomes in ST-Elevation Acute Myocardial Infarction
Tada, Y., Nakamura, T., Funayama, H., Sugawara, Y., Ako, J., Ishikawa, S., & Momomura, S. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0945 · Cited by 41
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department
Castello, L. M., Baldrighi, M., Panizza, A., Bartoli, E., & Avanzi, G. C. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1508-5 · Cited by 41
Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure
Pedersen, E. B., Danielsen, H., JENSEN, T., Madsen, M. G., Sørensen, S. S., & Thomsen, O. Ø. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01308.x · Cited by 39
Association of hyponatremia with increased renin activity in chronic congestive heart failure: Impact of diuretic therapy
Schaer, G. L., Covit, A. B., Laragh, J. H., & Cody, R. J. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90200-x · Cited by 38
Treatment of Hyponatremia
Schrier, R. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121709 · Cited by 38
Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice
Fujiwara, Y., Hiroyama, M., Sanbe, A., Yamauchi, J., Tsujimoto, G., & Tanoue, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.06864 · Cited by 36
Pathophysiology of renal fluid retention
Schrier, R. W., Fassett, R. G., Ohara, M., & Martin, P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06724.x · Cited by 35
Concepts of Scientific Integrative Medicine Applied to the Physiology and Pathophysiology of Catecholamine Systems
Goldstein, D. S. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130006 · Cited by 34
Prognosis in Congestive Heart Failure
DOMANSKI, M. J., Garg, R., & Yusuf, S. (1994) · Springer eBooks · doi:10.1007/978-1-4613-8315-4_33 · Cited by 34
Pathogenesis of Sodium and Water Retention in Cardiac Failure
Schrier, R. W., & Fassett, R. G. (1998) · Renal Failure · doi:10.3109/08860229809045175 · Cited by 32
Vasopressin dysregulation: Hyponatremia, fluid retention and congestive heart failure
LeJemtel, T. H., & Serrano, C. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.113 · Cited by 30
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction
Wada, K., Tahara, A., Arai, Y., Aoki, M., Tomura, Y., Tsukada, J., & Yatsu, T. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02101-5 · Cited by 28
EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS
Yatsu, T. (2002) · Pharmacological Research · doi:10.1016/s1043661802002062 · Cited by 27
Neurohumoral activation in congestive heart failure
Mancia, G. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90054-2 · Cited by 27
Arginine Vasopressin Levels Are Elevated and Correlate With Functional Status in Infants and Children With Congestive Heart Failure
Price, J. F., Towbin, J. A., Denfield, S. W., Clunie, S. K., Smith, E. O., McMahon, C. J., Radovančević, B., & Dreyer, W. J. (2004) · Circulation · doi:10.1161/01.cir.0000129764.84596.eb · Cited by 26
Baroreflex loading maneuvers do not suppress increased plasma arginine vasopressin in patients with congestive heart failure
Goldsmith, S. R. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90321-d · Cited by 26
Regional blood flow in human congestive heart failure
Leier, C. V. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90284-3 · Cited by 26
Renal Hemodynamic Changes in Heart Failure
Blankstein, R., & Bakris, G. L. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.03.006 · Cited by 23
Vasopressin, cortisol, and catecholamine concentrations in dogs with dilated cardiomyopathy
Tidholm, A., Häggström, J. U., & Hansson, K. (2005) · American Journal of Veterinary Research · doi:10.2460/ajvr.2005.66.1709 · Cited by 23
Sodium, Water, and Congestive Heart Failure
Hamilton, R. W., & BUCKALEW, V. M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-902 · Cited by 23
Electrolyte disturbances in chronic heart failure: Metabolic and clinical aspects
Cas, L. D., Metra, M., & Leier, C. V. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180704 · Cited by 22
Electrolyte disorders in the elderly
Lye, M. (1984) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(84)80027-4 · Cited by 22
Neurocardiology: Therapeutic Implications for Cardiovascular Disease
Goldstein, D. S. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00244.x · Cited by 21
Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles
PUNZENGRUBER, C., Stanek, B., Sinzinger, H. F., & Silberbauer, K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90846-5 · Cited by 21
Diuretic Resistance in Heart Failure
Rahman, R. N., Paz, P., Elmassry, M., Mantilla, B., Dobbe, L., Shurmur, S. W., & NUGENT, K. M. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000310 · Cited by 20
Variable arginine vasopressin levels in neonatal congestive heart failure
Stewart, J. M., Zeballos, G. A., Woolf, P. K., Dweck, H. S., & Gewitz, M. H. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)91544-6 · Cited by 20
Neurohormonal Influences in the Pathogenesis of Congestive Heart Failure
Cody, R. J. (1989) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30458-2 · Cited by 20
Interrelation of electrolytes and renin-angiotensin system in congestive heart failure
Dargie, H. J. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90249-z · Cited by 18
Activation of the neuroendocrine response in heart failure: Adaptive or maladaptive process?
Ferrari, R., Ceconi, C., Curello, S., Ferrari, F. S., Confortini, R., Pepi, P., & Visioli, O. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00052509 · Cited by 18
Validation of a commercially available enzyme immunoassay for measurement of plasma antidiuretic hormone concentration in healthy dogs and assessment of plasma antidiuretic hormone concentration in dogs with congestive heart failure
Scollan, K. F., Bulmer, B. J., & Sisson, D. D. (2013) · American Journal of Veterinary Research · doi:10.2460/ajvr.74.9.1206 · Cited by 17
Thoroughly Calibrated Modular Agent-Based Model of the Human Cardiovascular and Renal Systems for Blood Pressure Regulation in Health and Disease
Kutumova, E., Kiselev, I., Sharipov, R., Lifshits, G., & Kolpakov, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746300 · Cited by 16
Hemodynamic factors associated with serum chloride in ambulatory patients with advanced heart failure
Grodin, J. L., Müllens, W., Dupont, M., Taylor, D. O., McKie, P. M., Starling, R. C., Testani, J. M., & Tang, W. H. W. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.024 · Cited by 16

Authors: Riegger, G. A. J., Liebau, G., & Kochsiek, K.
Corresponding author: Riegger, Günther A.J.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 1982-01
Volume: 72
Issue: 1
Pages: 49-52
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/0002-9343(82)90576-9
OpenAlex: W2011628654
Cited by: 193
References: 25
Citations by year: 2025: 2 · 2023: 1 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 5 · 2012: 1
FWCI: 17.96
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords: vasopressin, congestive heart failure, hyponatremia, plasma osmolality, prazosin, atrial receptors, hemofiltration, osmoregulation, left atrial pressure, volume receptors
MeSH terms: Adult, Edema, Heart Failure, Hemodynamics, Humans, Hyponatremia, Middle Aged, Osmolar Concentration, Prazosin, Vasopressins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Antidiuretic hormone in congestive heart failure.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks

Data sources